eXoZymes, Inc.
NASDAQ: EXOZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Heltzen
- Employees
- 31
- Headquarters
- Monrovia, United States
- IPO year
- 2024
- Market cap
- $60.5M
- Website
- https://exozymes.com
Loading EXOZ…
Loading profile data…Frequently asked questions about EXOZ
What does eXoZymes, Inc. (EXOZ) do?
Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a diverse spectrum of chemicals. This output encompasses essential pharmaceuticals, alternative fuels, advanced materials, food additives, and entir...
Where does EXOZ trade?
eXoZymes, Inc. (EXOZ) trades on the NASDAQ Global Market.
What sector is EXOZ in?
eXoZymes, Inc. (EXOZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of eXoZymes, Inc.?
Michael Heltzen is the chief executive officer of eXoZymes, Inc. (EXOZ).
Where is eXoZymes, Inc. headquartered?
eXoZymes, Inc. is headquartered in United States.
Does EXOZ pay a dividend?
eXoZymes, Inc. (EXOZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EXOZ go public?
eXoZymes, Inc. (EXOZ) completed its initial public offering in 2024.